Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

By Palos Isidro   Lara-Ramirez Edgar E.   Lopez-Cedillo Julio Cesar   Garcia-Perez Carlos   Kashif Muhammad   Bocanegra-Garcia Virgilio   Nogueda-Torres Benjamin   Rivera Gildardo  

Molecules, Vol. 22, Iss. 6, 2017-06 ,pp. : 1015-1015

MDPI

Access to resources Recommend Favorite

Synthesis and Anti-Trypanosoma cruzi Activity of Diaryldiazepines

By Menezes Júlio César L.   Vaz Luana Beatriz A.   Vieira Paula Melo de Abreu   Fonseca Kátia da Silva   Carneiro Cláudia Martins   Taylor Jason G.  

Molecules, Vol. 20, Iss. 1, 2014-12 ,pp. : 43-51

MDPI

Access to resources Recommend Favorite

Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment

By Vernot Jean-Paul   Bonilla Ximena   Rodriguez-Pardo Viviana   Vanegas Natalia-Del Pilar  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 199-199

MDPI

Access to resources Recommend Favorite

Camalexin-Induced Apoptosis in Prostate Cancer Cells Involves Alterations of Expression and Activity of Lysosomal Protease Cathepsin D

By Smith Basil   Randle Diandra   Mezencev Roman   Thomas LeeShawn   Hinton Cimona   Marah Valerie  

Molecules, Vol. 19, Iss. 4, 2014-04 ,pp. : 3988-4005

MDPI

Access to resources Recommend Favorite

Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.

By Álvarez Guzmán   Perdomo Cintya   Coronel Cathia   Aguilera Elena   Varela Javier   Aparicio Gonzalo   Zolessi Flavio R.   Cabrera Nallely   Vega Celeste   Rolón Miriam   Rojas de Arias Antonieta   Pérez-Montfort Ruy   Cerecetto Hugo   González Mercedes  

Molecules, Vol. 22, Iss. 5, 2017-05 ,pp. : 709-709

MDPI

Access to resources Recommend Favorite